Top Story

Do International Cannabis Companies Deserve More Attention?
March 2nd, 2021 - Ryan Allway
Since the legal cannabis industry burst onto investors’ radar in 2014 the U.S. market and the Canadian markets have been the primary focus. The potential of the U.S. market ...
Top News

Kaya Holdings,Inc.’s Cannabis Retailer Kaya Shack™ Launches “Pot 4 a Shot” Vaccination Appreciation Program
March 3rd, 2021 - Ryan Allway

Psychedelic Wellness-Focused Company DELIC Holdings Announces Appointment of Kyle Snook to Board of Advisors
March 2nd, 2021 - Ryan Allway
Public Companies
Private Companies & Entrepreneurs
Cannabis & CBD

International Women’s Day Event Brings Together Women in the Cannabis & Psychedelics Industries
March 3rd, 2021 - Ryan Allway

Green Thumb Industries and California’s #1 Cannabis-Infused Beverage Cann Announce Partnership to Expand Nationally
March 3rd, 2021 - Ryan Allway

SpeakEasy Proves High Quality High Margin Product Strategy with its Indoor Craft Flower Sales and Outlook for 2021
March 3rd, 2021 - Ryan Allway

Tetra Bio-Pharma Announces Closing of Bought Deal Offering
March 3rd, 2021 - Ryan Allway

HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
March 3rd, 2021 - Ryan Allway

Kaya Holdings,Inc.’s Cannabis Retailer Kaya Shack™ Launches “Pot 4 a Shot” Vaccination Appreciation Program
March 3rd, 2021 - Ryan Allway

Forian Launched Through Combination of Helix Technologies and Medical Outcomes Research Analytics
March 3rd, 2021 - Ryan Allway
Psychedelics & Mushrooms

Cybin Inc. Announces Uplisting to OTCQB Venture Market
March 3rd, 2021 - Ryan Allway

Entheon Biomedical Announces Nancy Maher, Special Advisor of Data Science and Regulatory Affairs
March 3rd, 2021 - Ryan Allway

Lobe Sciences Appoints NFL Alumni Association President, Bart Oates Esq. to Advisory Board
March 3rd, 2021 - Ryan Allway

MINDCURE Announces Manufacturing of Synthetic Ibogaine to be Used in Company’s Clinical Research
March 3rd, 2021 - Ryan Allway

Novamind Expands Leadership Team, Accelerating M&A
March 3rd, 2021 - Ryan Allway

Nova Mentis Launches Autism Microbiome Study in the United States
March 3rd, 2021 - Ryan Allway

Atai Life Sciences Announces the Closing of its $157 Million Series D Financing Round
March 3rd, 2021 - Ryan Allway

NeonMind Files Four Additional Provisional Patents on Psilocybin Preclinical Data
March 2nd, 2021 - Ryan Allway

Psyched Wellness Provides Update on Pre-Clinical Trial of its Muscimol Extract AME-1
March 2nd, 2021 - Ryan Allway
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer